You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AC220

Showing 1 - 25 of 471
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,

Completed
Has Results
  • Lymphoblastic Leukemia, Acute, Childhood
  • Myelogenous Leukemia, Acute, Childhood
  • AC220
  • +3 more
  • Los Angeles, California
  • +10 more
Mar 24, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
May 23, 2022

Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

Completed
  • Acute Myeloid Leukemia (AML)
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Jul 27, 2022

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

Unknown status
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 9, 2020

Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome Trial in Georgia, United States (AC220)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • AC220
  • Birmingham, Alabama
  • +4 more
Apr 23, 2020

Acute Myeloid Leukemia With FLT3/ITD Mutation, Recurrent Acute Myeloid Leukemia, Refractory Acute Leukemia Trial in Houston

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 13, 2020

Leukemia, Myeloid, Acute Trial in Japan (Quizartinib)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • Aichi, Japan
  • +26 more
Feb 4, 2020

Solid Tumors Trial in Boston, San Antonio (Compound AC220)

Completed
  • Solid Tumors
  • Compound AC220
  • Boston, Massachusetts
  • +1 more
Feb 8, 2019

Leukemia, Myeloid, Acute Trial in Worldwide (AC220)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • AC220
  • Los Angeles, California
  • +23 more
Dec 20, 2019

Acute Myeloid Leukemia Trial in Worldwide (Compound AC220)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Compound AC220
  • San Francisco, California
  • +84 more
Dec 3, 2019

Leukemia, Myeloid, Acute Trial in United States (AC220)

Completed
  • Leukemia, Myeloid, Acute
  • AC220
  • Duarte, California
  • +4 more
Feb 8, 2019

Leukemia, Myeloid, Acute Trial in United States (AC220, daunorubicin, cytarabine)

Completed
  • Leukemia, Myeloid, Acute
  • AC220
  • +2 more
  • Jacksonville, Florida
  • +4 more
Feb 8, 2019

Chronic Diabetic Foot Ulcer Trial in Cairo (Shock wave therapy, Vacuum-assisted closure)

Completed
  • Chronic Diabetic Foot Ulcer
  • Shock wave therapy
  • Vacuum-assisted closure
  • Cairo, Egypt
    Shaimaa Mohamed Ahmed El Sayeh
May 5, 2023

Bone Metastasis, Cancer Pain Trial in Worldwide (Tanezumab)

Completed
Has Results
  • Bone Metastasis
  • Cancer Pain
  • Rosario, Santa FE, Argentina
  • +88 more
Dec 21, 2022

Relapsed AML, Refractory AML Trial in Tokyo (AC220)

Completed
  • Relapsed AML
  • Refractory AML
  • AC220
  • Tokyo, Japan
    (unnamed)
Feb 8, 2019

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)

Recruiting
  • Major Depressive Disorder
  • stepwise pharamacotherapy
  • antidepressant monotherapy group
  • Gwangju, Korea, Republic of
    Chonnam National University Hospital
Sep 19, 2023

Bladder Tumor Trial in Gwangju (Rocuronium Bromide, Nerve stimulator)

Not yet recruiting
  • Bladder Tumor
  • Rocuronium Bromide
  • Nerve stimulator
  • Gwangju, Korea, Republic of
    Chosun University Hospital
May 22, 2023

Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)

Completed
Has Results
  • Healthy Subjects
  • Quizartinib dihydrochloride
  • 14C-Quizartinib solution for infusion
  • Nottingham, United Kingdom
    Quotient Sciences
Apr 15, 2022

Surgery Trial in Gwangju (Esophageal temperature monitoring according to the depth, Anatomical landmark)

Recruiting
  • Surgery
  • Esophageal temperature monitoring according to the depth
  • Anatomical landmark
  • Gwangju, Korea, Republic of
    Chosun University Hospital
Oct 13, 2022